Effects of asymmetric dimethylarginine on renal arteries in portal hypertension and cirrhosis

doi:10.3748/wjg.v22.i48.10545

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 48

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7193)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-4) series.

Item

Count

PDF

435

WORD

287

HTML

3054

Figures (1-5)

297

Tables (1-4)

247

Sum=4320

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

874

Download

1999

Sum=2873

Dec 28, 2016 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Dec 28, 2016; 22(48): 10545-10556
Published online Dec 28, 2016. doi: 10.3748/wjg.v22.i48.10545

Full Size Figure Download Figure

Figure 5 Effects of portal hypertension and cirrhosis on renal dimethylarginine dimethylaminohydrolase activity. Bar graphs represent DDAH activity in kidney from Sham, PPVL, and BDL groups. Each data set represents the mean ± SEM derived from 6 independent experiments. ^aP < 0.05 vs Sham group and ^cP < 0.05 vs PPVL group. DDAH: Dimethylarginine dimethylaminohydrolase.

Citation: Segarra G, Cortina B, Mauricio MD, Novella S, Lluch P, Navarrete-Navarro J, Noguera I, Medina P. Effects of asymmetric dimethylarginine on renal arteries in portal hypertension and cirrhosis. World J Gastroenterol 2016; 22(48): 10545-10556
URL: https://www.wjgnet.com/1007-9327/full/v22/i48/10545.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i48.10545